Please login to the form below

Not currently logged in
Email:
Password:

R&D news in brief

Our weekly round-up of the R&D news in brief
GSK announces Irish R&D centre
GlaxoSmithKline is to establish a Ä13.7m research centre into gastrointestinal diseases in Cork. Researchers from GSK's Neurology and GI Centre of Excellence for Drug Discovery (CEDD) will work closely with the Alimentary Pharmabiotic Centre (APC) to identify new drug targets for the treatment of inflammatory bowel disease and irritable bowel syndrome. Speaking at the launch, Irish Minister for Enterprise, Trade and Employment, Miche·l Martin, said: "This project represents a major breakthrough in the promotion of drug discovery research, whichÖ builds on the government's strategy to actively promote industrial-academic collaborations."

HIV 'switch' clue
Scientists in the US say they have discovered how the HIV virus manages to evade T cells sent out by the body's immune system to fight it. They said HIV flicks a molecular switch on T cells, disarming them. In the laboratory, the team from Howard Hughes Medical Institute at Massachusetts General Hospital, were able to block this switch and restore T cell function. The scientists said that drugs already designed to target T cells in this way may not be specific enough and could cause serious side effects. "One has to proceed with real caution because if you turn back on an immune regulatory switch that the body has decided to turn off, you could trigger serious immunological problems," said lead researcher, Bruce Walker.

30th September 2008

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics